NCT06483659View on ClinicalTrials.gov

Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

December 1, 2025

Conditions

Postoperative Pain

Interventions

DRUG

Oxytocin

Intravenous Oxytocin infusion

DRUG

Placebo

0.9% Saline

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER